Could a novel therapeutic halt Parkinson’s disease progression?
Scientists from Johns Hopkins University have developed a novel therapeutic, shown to slow the progression of Parkinson’s disease and its symptoms in live mouse models.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.